GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Hypha Labs Inc (OTCPK:DIGP) » Definitions » Cyclically Adjusted PB Ratio

Hypha Labs (Hypha Labs) Cyclically Adjusted PB Ratio : 0.34 (As of May. 15, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Hypha Labs Cyclically Adjusted PB Ratio?

As of today (2024-05-15), Hypha Labs's current share price is $0.0307. Hypha Labs's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was $0.09. Hypha Labs's Cyclically Adjusted PB Ratio for today is 0.34.

The historical rank and industry rank for Hypha Labs's Cyclically Adjusted PB Ratio or its related term are showing as below:

DIGP' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.13   Med: 0.33   Max: 0.78
Current: 0.33

During the past years, Hypha Labs's highest Cyclically Adjusted PB Ratio was 0.78. The lowest was 0.13. And the median was 0.33.

DIGP's Cyclically Adjusted PB Ratio is ranked better than
81.95% of 133 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.02 vs DIGP: 0.33

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Hypha Labs's adjusted book value per share data for the three months ended in Dec. 2023 was $-0.024. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.09 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Hypha Labs Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Hypha Labs's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hypha Labs Cyclically Adjusted PB Ratio Chart

Hypha Labs Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.26

Hypha Labs Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 0.28 0.26 0.44

Competitive Comparison of Hypha Labs's Cyclically Adjusted PB Ratio

For the Diagnostics & Research subindustry, Hypha Labs's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hypha Labs's Cyclically Adjusted PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Hypha Labs's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Hypha Labs's Cyclically Adjusted PB Ratio falls into.



Hypha Labs Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Hypha Labs's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.0307/0.09
=0.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hypha Labs's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Hypha Labs's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.024/129.4194*129.4194
=-0.024

Current CPI (Dec. 2023) = 129.4194.

Hypha Labs Quarterly Data

Book Value per Share CPI Adj_Book
201403 -1.506 99.695 -1.955
201406 1.465 100.560 1.885
201409 0.991 100.428 1.277
201412 0.602 99.070 0.786
201503 0.453 99.621 0.588
201506 0.288 100.684 0.370
201509 0.171 100.392 0.220
201512 0.098 99.792 0.127
201603 0.076 100.470 0.098
201606 0.064 101.688 0.081
201609 0.055 101.861 0.070
201612 0.049 101.863 0.062
201703 0.048 102.862 0.060
201706 0.040 103.349 0.050
201709 0.040 104.136 0.050
201712 0.049 104.011 0.061
201803 0.033 105.290 0.041
201806 0.027 106.317 0.033
201809 0.024 106.507 0.029
201812 0.018 105.998 0.022
201903 0.023 107.251 0.028
201906 0.015 108.070 0.018
201909 0.009 108.329 0.011
201912 0.005 108.420 0.006
202003 0.003 108.902 0.004
202006 -0.004 108.767 -0.005
202009 -0.019 109.815 -0.022
202012 -0.020 109.897 -0.024
202103 -0.016 111.754 -0.019
202106 -0.017 114.631 -0.019
202109 -0.015 115.734 -0.017
202112 -0.021 117.630 -0.023
202203 -0.024 121.301 -0.026
202206 -0.031 125.017 -0.032
202209 -0.037 125.227 -0.038
202212 -0.035 125.222 -0.036
202303 -0.035 127.348 -0.036
202306 -0.028 128.729 -0.028
202309 -0.025 129.860 -0.025
202312 -0.024 129.419 -0.024

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Hypha Labs  (OTCPK:DIGP) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Hypha Labs Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Hypha Labs's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Hypha Labs (Hypha Labs) Business Description

Traded in Other Exchanges
N/A
Address
6450 Cameron Street, Suite 113, Las Vegas, NV, USA, 89118
DigiPath Inc is engaged in providing pharmaceutical-grade analysis and testing cannabis education and training and brings unbiased cannabis news coverage to the cannabis industry. It screens medicinal cannabis for potentially harmful contaminants, including solvents, pesticides, mold and yeast, heavy metals such as mercury, arsenic, cadmium, and others. It also tests cannabis for its quality, potency, and cannabinoid and terpene profiles, which determine the suitability of specific cannabis strains for the treatment of specific ailments.
Executives
A Stone Douglass director 10200 WILLOW CREEK ROAD, SAN DIEGO CA 92131
Edmond Defrank director 19360 RINALDI STREET, #448, NORTHRIDGE CA 91326
Kyle Remenda officer: Chief Executive Officer 111-2532 SHORELINE DRIVE, LAKE COUNTRY A1 V4V2R6
Dennis Hartmann director 1600 CAMDEN AVENUE, NO. 103, LOS ANGELES CA 90025
Bruce I Raben director 430 VICTORIA TERRACE, RIDGEFIELD NJ 7657
Cindy Sue Orser director 4507 APPLE WAY, BOULDER CO 80301
Alfredo Axtmayer director 287 PAYNE DRIVE, CHESHIRE CT 06410
Joseph J Bianco director 611 BROADWAY,, SUITE 307, NEW YORK NY 10012
Todd A Peterson officer: Chief Financial Officer 3608 MALLARDWOOD DRIVE, LAS VEGAS NV 89129
Joe D Tanner director 28720 ROADSIDE DRIVE, SUITE 128, AGOURA HILLS CA 91301
Raw Alternative, Llc 10 percent owner 16030 VENTURA BLVD. SUITE 380, ENCINO CA 91436
Todd Denkin director, officer: President C/O PHOTOTRON, INC., 20259 VENTURA BLVD., WOODLAND HILLS CA 91364
Barbee Denny Barbee 10 percent owner 3105 EAST CENTRAL, #114, WICHITA KS 67214
Eric Stoppenhagen director, 10 percent owner, officer: CFO 8908 SPLITARROW DRIVE, AUSTIN TX 78717